Cas no 5465-30-5 (1-Butyl-1H-benzimidazole)
1-Butyl-1H-benzimidazole Chemical and Physical Properties
Names and Identifiers
-
- 1-Butyl-1H-benzo[d]imidazole hydrochloride
- 1-BUTYLBENZOIMIDAZOLE
- 1-butyl-1H-1,3-benzodiazole
- 1-Butyl-1H-benzimidazole hydrochloride
- 1-butylbenzimidazole;hydrochloride
- NSC-28963
- NSC28963
- 5465-30-5
- DB-328886
- 1-Butyl-1H-benzimidazole
-
- MDL: MFCD00464045
- Inchi: 1S/C11H14N2.ClH/c1-2-3-8-13-9-12-10-6-4-5-7-11(10)13;/h4-7,9H,2-3,8H2,1H3;1H
- InChI Key: RYRHKHOZMNMZNV-UHFFFAOYSA-N
- SMILES: Cl.N1(C=NC2C=CC=CC1=2)CCCC
Computed Properties
- Exact Mass: 174.11600
- Monoisotopic Mass: 210.092
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 14
- Rotatable Bond Count: 3
- Complexity: 158
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 17.8A^2
Experimental Properties
- Density: 1.04
- Boiling Point: 296.9 °C at 760 mmHg
- Flash Point: 133.4 °C
- Refractive Index: 1.571
- PSA: 17.82000
- LogP: 2.83640
1-Butyl-1H-benzimidazole Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
1-Butyl-1H-benzimidazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B281415-50mg |
1-Butyl-1H-benzimidazole |
5465-30-5 | 50mg |
$ 170.00 | 2022-06-07 | ||
| TRC | B281415-100mg |
1-Butyl-1H-benzimidazole |
5465-30-5 | 100mg |
$ 280.00 | 2022-06-07 | ||
| TRC | B281415-250mg |
1-Butyl-1H-benzimidazole |
5465-30-5 | 250mg |
$ 555.00 | 2022-06-07 | ||
| Alichem | A069002681-5g |
1-Butyl-1H-benzo[d]imidazole hydrochloride |
5465-30-5 | 95% | 5g |
$414.72 | 2023-09-01 | |
| Chemenu | CM155047-5g |
1-Butyl-1H-benzo[d]imidazole hydrochloride |
5465-30-5 | 95% | 5g |
$445 | 2021-06-08 | |
| Chemenu | CM155047-5g |
1-Butyl-1H-benzo[d]imidazole hydrochloride |
5465-30-5 | 95% | 5g |
$*** | 2023-05-30 | |
| Crysdot LLC | CD11106617-5g |
1-Butyl-1H-benzo[d]imidazole hydrochloride |
5465-30-5 | 95+% | 5g |
$470 | 2024-07-18 |
1-Butyl-1H-benzimidazole Related Literature
-
Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
Additional information on 1-Butyl-1H-benzimidazole
Comprehensive Guide to 1-Butyl-1H-benzimidazole (CAS No. 5465-30-5): Properties, Applications, and Industry Insights
1-Butyl-1H-benzimidazole (CAS No. 5465-30-5) is a versatile organic compound belonging to the benzimidazole family. This heterocyclic compound has garnered significant attention in recent years due to its unique chemical properties and broad applicability across industries. With the rise of green chemistry and sustainable materials, researchers are increasingly exploring derivatives like 1-Butyl-1H-benzimidazole as potential alternatives to traditional synthetic intermediates.
The molecular structure of 1-Butyl-1H-benzimidazole features a benzene ring fused with an imidazole ring, substituted with a butyl group at the 1-position. This configuration contributes to its moderate polarity and excellent thermal stability, making it valuable for various high-temperature applications. Recent studies published in ACS Sustainable Chemistry & Engineering highlight its potential as a corrosion inhibitor in industrial systems, addressing growing concerns about metal degradation in harsh environments.
In the pharmaceutical sector, 1-Butyl-1H-benzimidazole serves as a crucial building block for drug discovery. The benzimidazole scaffold is known for its bioactive properties, appearing in numerous FDA-approved medications. While this specific derivative isn't itself a drug, its structural features make it valuable for developing targeted therapies, particularly in the context of antimicrobial resistance – a top global health concern according to WHO reports.
Material scientists have explored 5465-30-5 for advanced applications in organic electronics. Its conjugated system and ability to coordinate with metals make it promising for OLED technologies and conductive polymers. With the flexible electronics market projected to reach $87 billion by 2027 (MarketsandMarkets data), compounds like 1-Butyl-1H-benzimidazole are gaining traction as potential components in next-generation wearable devices and smart materials.
The synthesis of 1-Butyl-1H-benzimidazole typically involves condensation reactions between o-phenylenediamine derivatives and butyl-containing precursors. Modern flow chemistry techniques have improved the efficiency of this process, reducing waste and energy consumption – key considerations in today's eco-conscious manufacturing landscape. Analytical characterization commonly employs HPLC, NMR spectroscopy, and mass spectrometry to ensure purity and confirm structural integrity.
Environmental considerations surrounding benzimidazole compounds have become increasingly important. Recent lifecycle assessments suggest that proper handling and disposal of 1-Butyl-1H-benzimidazole can minimize ecological impact. The compound's biodegradability profile and potential for green synthesis pathways align with the principles of circular economy, making it an attractive subject for green chemistry research initiatives worldwide.
From a commercial perspective, the global market for benzimidazole derivatives continues to expand, driven by demand from pharmaceutical intermediates and specialty chemicals sectors. 1-Butyl-1H-benzimidazole occupies a niche position in this market, with suppliers offering various purity grades (typically 95-99%) to meet diverse application requirements. Quality control measures have become more stringent in response to growing emphasis on supply chain transparency and material traceability.
Emerging research directions for 5465-30-5 include exploration as a ligand in catalysis and potential applications in energy storage systems. The compound's electron-rich structure shows promise for developing more efficient redox flow batteries, addressing critical needs in renewable energy integration. These developments position 1-Butyl-1H-benzimidazole as a compound of interest in the transition toward carbon-neutral technologies.
Safety considerations for handling 1-Butyl-1H-benzimidazole follow standard laboratory protocols for organic compounds. While not classified as hazardous under normal conditions, proper personal protective equipment (PPE) including gloves and safety glasses is recommended. Storage typically requires protection from moisture and extreme temperatures to maintain stability, with many suppliers recommending argon-filled containers for long-term preservation of sensitive batches.
The future outlook for 1-Butyl-1H-benzimidazole appears promising, particularly as interdisciplinary research uncovers novel applications. Its combination of structural versatility and tunable properties makes it a valuable tool for chemists working in materials science, medicinal chemistry, and industrial applications. As synthetic methodologies advance and characterization techniques improve, we can expect to see expanded utilization of this compound in cutting-edge technologies addressing global challenges.
5465-30-5 (1-Butyl-1H-benzimidazole) Related Products
- 4886-30-0(1-Butyl-1H-benzo[d]imidazole)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)